Vivelle-Dot vs. Bijuva

See how Vivelle-Dot and Bijuva compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Vivelle-Dot is an estrogen-only patch changed twice a week, while Bijuva is a combined estrogen-progesterone capsule swallowed once a day.

  • Vivelle-Dot has extra FDA approvals for vaginal atrophy, ovarian failure, and osteoporosis prevention that Bijuva does not carry.

  • Because Bijuva already contains progesterone, it protects the uterine lining without needing a second prescription for women who have a uterus.

Vivelle-Dot vs. Bijuva Drug Summary

Vivelle-Dot

Vivelle-Dot is an estrogen-only hormone therapy patch containing estradiol. It treats hot flashes, vaginal dryness from menopause, and low estrogen from ovarian failure, and can help prevent postmenopausal bone loss. It's applied to the abdomen or buttocks and replaced twice weekly.

Bijuva

Bijuva is a combination hormone therapy capsule containing bioidentical estradiol and progesterone. It treats moderate to severe hot flashes in menopausal women who still have a uterus, delivering both hormones together in one capsule. It's swallowed once daily, ideally with food to boost absorption.

Vivelle-Dot vs. Bijuva Side Effects

Vivelle-Dot

Most common
Headache (up to 24%)
Breast tenderness (up to 20%)
Sinusitis (up to 13%)
Sinus headache (up to 11%)

Bijuva

Most common
Headache (up to 3.4%)
Breast tenderness (up to 10.4%)
Vaginal bleeding (up to 3.4%)
Nausea (up to 2.2%)

Vivelle-Dot vs. Bijuva Dosage

Vivelle-Dot

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.0375 mg/day patch At the start
Maximum dose 0.025 mg/day patch If needed
Dose changes 2 increases As tolerated

Bijuva

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.5 mg/100 mg once daily At the start
Maximum dose 1 mg/100 mg once daily If needed
Dose changes 1 increase As tolerated

Vivelle-Dot vs. Bijuva Indications

Vivelle-Dot

Vivelle-Dot is FDA-approved for several menopause-related conditions beyond hot flashes. It also treats vaginal atrophy, replaces estrogen lost to ovarian failure or removal, and helps prevent bone loss after menopause when other options aren't suitable.

  • Moderate to severe hot flashes and night sweats from menopause

  • Moderate to severe vaginal dryness and irritation from menopause

  • Low estrogen from ovarian failure, removal, or hypogonadism

  • Prevention of postmenopausal osteoporosis when other options aren't suitable

Bijuva

Bijuva is FDA-approved for one specific use: moderate to severe hot flashes from menopause. It's built only for women who still have a uterus, since its progesterone component protects the uterine lining from unopposed estrogen.

  • Moderate to severe hot flashes and night sweats from menopause

  • Approved specifically for women who still have a uterus

  • Combines estrogen and progesterone in one daily capsule

  • Not approved for osteoporosis prevention or vaginal atrophy alone

Vivelle-Dot vs. Bijuva Pros and Cons

Vivelle-Dot

Vivelle-Dot delivers estrogen through the skin, avoiding the liver metabolism that oral estrogens go through, and it comes in five dose strengths for fine-tuning. Because it doesn't contain progesterone, women with a uterus need to add a separate progestin. Coverage varies by plan, and ongoing shortages have made both brand and generic patches harder to find at times.

Pros

  • Transdermal delivery skips first-pass liver metabolism, unlike oral hormones

  • Five dose strengths (0.025 to 0.1 mg/day) allow precise titration

  • Also approved for vaginal atrophy, ovarian failure, and osteoporosis prevention

  • Generic estradiol patches exist, often $30 to $80 a month without insurance

Cons

  • Requires a separate progestin prescription for women with a uterus

  • Patch can cause skin redness, irritation, or detachment at the site

  • Brand-name and generic patches have faced ongoing supply shortages

Bijuva

Bijuva pairs bioidentical estradiol with bioidentical progesterone in a single capsule, so women with a uterus don't need a second prescription for endometrial protection. It's approved only for hot flashes, without the broader menopause indications Vivelle-Dot carries. There's no generic version, and absorption depends on taking it consistently with food.

Pros

  • Combines bioidentical estradiol and progesterone in one daily capsule

  • Already protects the uterine lining, no separate progestin needed

  • Only FDA-approved product pairing bioidentical estradiol with progesterone

  • No patch, so no adhesive or skin site issues

Cons

  • Only approved for hot flashes, not vaginal atrophy or osteoporosis prevention

  • Cannot be used in women without a uterus

  • No generic version, brand-only pricing runs roughly $257 to $351 a month

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.